MPH Health Care AG
XETRA: 93M1.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Patrick Brenske
- Employees
- 2
- Headquarters
- Berlin, Germany
- IPO year
- 2011
- Market cap
- €92.0M
- Website
- https://www.mph-ag.de
Loading 93M1…
Loading profile data…Frequently asked questions about 93M1
What does MPH Health Care AG (93M1.DE) do?
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well a...
Where does 93M1.DE trade?
MPH Health Care AG (93M1.DE) trades on the Deutsche Börse.
What sector is 93M1.DE in?
MPH Health Care AG (93M1.DE) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of MPH Health Care AG?
Patrick Brenske is the chief executive officer of MPH Health Care AG (93M1.DE).
Where is MPH Health Care AG headquartered?
MPH Health Care AG is headquartered in Germany.
Does 93M1.DE pay a dividend?
Yes — MPH Health Care AG (93M1.DE) paid a trailing twelve-month dividend of EUR 1.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 93M1.DE go public?
MPH Health Care AG (93M1.DE) completed its initial public offering in 2011.